nodes	percent_of_prediction	percent_of_DWPC	metapath
Glimepiride—Paresis—Temozolomide—malignant glioma	0.0422	0.0481	CcSEcCtD
Glimepiride—Disorder sight—Temozolomide—malignant glioma	0.0324	0.0369	CcSEcCtD
Glimepiride—Cerebration impaired—Temozolomide—malignant glioma	0.0262	0.0299	CcSEcCtD
Glimepiride—Aphasia—Carmustine—malignant glioma	0.0246	0.028	CcSEcCtD
Glimepiride—Aphasia—Temozolomide—malignant glioma	0.0238	0.0271	CcSEcCtD
Glimepiride—Cholestasis—Temozolomide—malignant glioma	0.0203	0.0231	CcSEcCtD
Glimepiride—Gliclazide—VEGFA—malignant glioma	0.0186	0.334	CrCbGaD
Glimepiride—Speech disorder—Carmustine—malignant glioma	0.0185	0.0211	CcSEcCtD
Glimepiride—Accidental injury—Carmustine—malignant glioma	0.018	0.0205	CcSEcCtD
Glimepiride—Speech disorder—Temozolomide—malignant glioma	0.0179	0.0204	CcSEcCtD
Glimepiride—Disturbance in attention—Temozolomide—malignant glioma	0.0178	0.0203	CcSEcCtD
Glimepiride—Hyperbilirubinaemia—Temozolomide—malignant glioma	0.0169	0.0193	CcSEcCtD
Glimepiride—Tolbutamide—CYP2C18—malignant glioma	0.0152	0.273	CrCbGaD
Glimepiride—Coma—Carmustine—malignant glioma	0.0146	0.0166	CcSEcCtD
Glimepiride—Aplastic anaemia—Temozolomide—malignant glioma	0.0145	0.0165	CcSEcCtD
Glimepiride—Glipizide—PPARG—malignant glioma	0.0143	0.256	CrCbGaD
Glimepiride—Mental disability—Carmustine—malignant glioma	0.0138	0.0158	CcSEcCtD
Glimepiride—Mental disability—Temozolomide—malignant glioma	0.0134	0.0152	CcSEcCtD
Glimepiride—Diabetes mellitus—Carmustine—malignant glioma	0.0133	0.0152	CcSEcCtD
Glimepiride—Injury—Carmustine—malignant glioma	0.0126	0.0143	CcSEcCtD
Glimepiride—Hepatic failure—Temozolomide—malignant glioma	0.0124	0.0142	CcSEcCtD
Glimepiride—Hot flush—Temozolomide—malignant glioma	0.012	0.0136	CcSEcCtD
Glimepiride—Menopausal symptoms—Temozolomide—malignant glioma	0.0119	0.0135	CcSEcCtD
Glimepiride—Hyponatraemia—Carmustine—malignant glioma	0.0116	0.0132	CcSEcCtD
Glimepiride—KCNJ1—telencephalon—malignant glioma	0.0106	0.159	CbGeAlD
Glimepiride—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.00987	0.0112	CcSEcCtD
Glimepiride—Abdominal distension—Temozolomide—malignant glioma	0.00973	0.0111	CcSEcCtD
Glimepiride—Pancytopenia—Carmustine—malignant glioma	0.0095	0.0108	CcSEcCtD
Glimepiride—Sweating increased—Temozolomide—malignant glioma	0.00942	0.0107	CcSEcCtD
Glimepiride—Pancytopenia—Temozolomide—malignant glioma	0.00918	0.0105	CcSEcCtD
Glimepiride—Pollakiuria—Temozolomide—malignant glioma	0.00893	0.0102	CcSEcCtD
Glimepiride—Photosensitivity reaction—Temozolomide—malignant glioma	0.00883	0.0101	CcSEcCtD
Glimepiride—Weight increased—Temozolomide—malignant glioma	0.0088	0.01	CcSEcCtD
Glimepiride—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.00855	0.00973	CcSEcCtD
Glimepiride—Hepatitis—Temozolomide—malignant glioma	0.00774	0.00881	CcSEcCtD
Glimepiride—Visual impairment—Carmustine—malignant glioma	0.00772	0.00879	CcSEcCtD
Glimepiride—Chlorpropamide—PTGS1—malignant glioma	0.00763	0.137	CrCbGaD
Glimepiride—Visual impairment—Temozolomide—malignant glioma	0.00746	0.00849	CcSEcCtD
Glimepiride—Erythema multiforme—Temozolomide—malignant glioma	0.00732	0.00833	CcSEcCtD
Glimepiride—Arrhythmia—Carmustine—malignant glioma	0.00715	0.00815	CcSEcCtD
Glimepiride—Erythema—Carmustine—malignant glioma	0.00697	0.00794	CcSEcCtD
Glimepiride—Malnutrition—Carmustine—malignant glioma	0.00697	0.00794	CcSEcCtD
Glimepiride—Malnutrition—Temozolomide—malignant glioma	0.00674	0.00767	CcSEcCtD
Glimepiride—Erythema—Temozolomide—malignant glioma	0.00674	0.00767	CcSEcCtD
Glimepiride—ABCC8—brainstem—malignant glioma	0.00664	0.1	CbGeAlD
Glimepiride—Vision blurred—Carmustine—malignant glioma	0.00657	0.00748	CcSEcCtD
Glimepiride—Tremor—Carmustine—malignant glioma	0.00653	0.00744	CcSEcCtD
Glimepiride—Anaemia—Carmustine—malignant glioma	0.00644	0.00734	CcSEcCtD
Glimepiride—Agitation—Carmustine—malignant glioma	0.00641	0.0073	CcSEcCtD
Glimepiride—Vision blurred—Temozolomide—malignant glioma	0.00635	0.00723	CcSEcCtD
Glimepiride—Tremor—Temozolomide—malignant glioma	0.00631	0.00719	CcSEcCtD
Glimepiride—Leukopenia—Carmustine—malignant glioma	0.00624	0.00711	CcSEcCtD
Glimepiride—Anaemia—Temozolomide—malignant glioma	0.00623	0.00709	CcSEcCtD
Glimepiride—Agitation—Temozolomide—malignant glioma	0.00619	0.00705	CcSEcCtD
Glimepiride—Angioedema—Temozolomide—malignant glioma	0.00616	0.00701	CcSEcCtD
Glimepiride—Convulsion—Carmustine—malignant glioma	0.00604	0.00688	CcSEcCtD
Glimepiride—Leukopenia—Temozolomide—malignant glioma	0.00603	0.00687	CcSEcCtD
Glimepiride—Hypertension—Carmustine—malignant glioma	0.00602	0.00686	CcSEcCtD
Glimepiride—KCNJ1—central nervous system—malignant glioma	0.006	0.0906	CbGeAlD
Glimepiride—Palpitations—Temozolomide—malignant glioma	0.00595	0.00678	CcSEcCtD
Glimepiride—Anxiety—Carmustine—malignant glioma	0.00591	0.00674	CcSEcCtD
Glimepiride—ABCC8—telencephalon—malignant glioma	0.0059	0.089	CbGeAlD
Glimepiride—Convulsion—Temozolomide—malignant glioma	0.00584	0.00665	CcSEcCtD
Glimepiride—Hypertension—Temozolomide—malignant glioma	0.00582	0.00662	CcSEcCtD
Glimepiride—Confusional state—Carmustine—malignant glioma	0.00574	0.00653	CcSEcCtD
Glimepiride—Anxiety—Temozolomide—malignant glioma	0.00572	0.00651	CcSEcCtD
Glimepiride—Dry mouth—Temozolomide—malignant glioma	0.00561	0.00639	CcSEcCtD
Glimepiride—Thrombocytopenia—Carmustine—malignant glioma	0.00557	0.00634	CcSEcCtD
Glimepiride—Tachycardia—Carmustine—malignant glioma	0.00555	0.00632	CcSEcCtD
Glimepiride—Confusional state—Temozolomide—malignant glioma	0.00554	0.00631	CcSEcCtD
Glimepiride—Anaphylactic shock—Temozolomide—malignant glioma	0.0055	0.00626	CcSEcCtD
Glimepiride—Anorexia—Carmustine—malignant glioma	0.00542	0.00618	CcSEcCtD
Glimepiride—Thrombocytopenia—Temozolomide—malignant glioma	0.00538	0.00613	CcSEcCtD
Glimepiride—Hypotension—Carmustine—malignant glioma	0.00532	0.00606	CcSEcCtD
Glimepiride—Hyperhidrosis—Temozolomide—malignant glioma	0.00532	0.00605	CcSEcCtD
Glimepiride—Anorexia—Temozolomide—malignant glioma	0.00524	0.00597	CcSEcCtD
Glimepiride—Insomnia—Carmustine—malignant glioma	0.00515	0.00586	CcSEcCtD
Glimepiride—Paraesthesia—Carmustine—malignant glioma	0.00511	0.00582	CcSEcCtD
Glimepiride—Dyspnoea—Carmustine—malignant glioma	0.00507	0.00578	CcSEcCtD
Glimepiride—Somnolence—Carmustine—malignant glioma	0.00506	0.00576	CcSEcCtD
Glimepiride—Insomnia—Temozolomide—malignant glioma	0.00497	0.00566	CcSEcCtD
Glimepiride—Decreased appetite—Carmustine—malignant glioma	0.00495	0.00563	CcSEcCtD
Glimepiride—Paraesthesia—Temozolomide—malignant glioma	0.00494	0.00562	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Carmustine—malignant glioma	0.00491	0.00559	CcSEcCtD
Glimepiride—Dyspnoea—Temozolomide—malignant glioma	0.0049	0.00558	CcSEcCtD
Glimepiride—Somnolence—Temozolomide—malignant glioma	0.00489	0.00557	CcSEcCtD
Glimepiride—Dyspepsia—Temozolomide—malignant glioma	0.00484	0.00551	CcSEcCtD
Glimepiride—Decreased appetite—Temozolomide—malignant glioma	0.00478	0.00544	CcSEcCtD
Glimepiride—KCNJ1—brain—malignant glioma	0.00476	0.0719	CbGeAlD
Glimepiride—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00475	0.00541	CcSEcCtD
Glimepiride—Fatigue—Temozolomide—malignant glioma	0.00474	0.0054	CcSEcCtD
Glimepiride—Feeling abnormal—Carmustine—malignant glioma	0.00469	0.00534	CcSEcCtD
Glimepiride—Gastrointestinal pain—Carmustine—malignant glioma	0.00465	0.0053	CcSEcCtD
Glimepiride—ABCC8—medulla oblongata—malignant glioma	0.00463	0.07	CbGeAlD
Glimepiride—Feeling abnormal—Temozolomide—malignant glioma	0.00453	0.00516	CcSEcCtD
Glimepiride—Abdominal pain—Carmustine—malignant glioma	0.0045	0.00512	CcSEcCtD
Glimepiride—Gastrointestinal pain—Temozolomide—malignant glioma	0.0045	0.00512	CcSEcCtD
Glimepiride—Urticaria—Temozolomide—malignant glioma	0.00437	0.00497	CcSEcCtD
Glimepiride—Abdominal pain—Temozolomide—malignant glioma	0.00435	0.00495	CcSEcCtD
Glimepiride—ABCC8—midbrain—malignant glioma	0.00423	0.0639	CbGeAlD
Glimepiride—Hypersensitivity—Carmustine—malignant glioma	0.00419	0.00477	CcSEcCtD
Glimepiride—ABCC8—spinal cord—malignant glioma	0.00413	0.0624	CbGeAlD
Glimepiride—Asthenia—Carmustine—malignant glioma	0.00408	0.00465	CcSEcCtD
Glimepiride—Hypersensitivity—Temozolomide—malignant glioma	0.00405	0.00461	CcSEcCtD
Glimepiride—Asthenia—Temozolomide—malignant glioma	0.00395	0.00449	CcSEcCtD
Glimepiride—Diarrhoea—Carmustine—malignant glioma	0.00389	0.00443	CcSEcCtD
Glimepiride—Pruritus—Temozolomide—malignant glioma	0.00389	0.00443	CcSEcCtD
Glimepiride—Dizziness—Carmustine—malignant glioma	0.00376	0.00429	CcSEcCtD
Glimepiride—Diarrhoea—Temozolomide—malignant glioma	0.00376	0.00428	CcSEcCtD
Glimepiride—KCNJ11—central nervous system—malignant glioma	0.00364	0.0549	CbGeAlD
Glimepiride—Dizziness—Temozolomide—malignant glioma	0.00364	0.00414	CcSEcCtD
Glimepiride—Vomiting—Carmustine—malignant glioma	0.00362	0.00412	CcSEcCtD
Glimepiride—Rash—Carmustine—malignant glioma	0.00359	0.00409	CcSEcCtD
Glimepiride—Dermatitis—Carmustine—malignant glioma	0.00358	0.00408	CcSEcCtD
Glimepiride—Headache—Carmustine—malignant glioma	0.00356	0.00406	CcSEcCtD
Glimepiride—KCNJ11—cerebellum—malignant glioma	0.00356	0.0537	CbGeAlD
Glimepiride—Vomiting—Temozolomide—malignant glioma	0.0035	0.00398	CcSEcCtD
Glimepiride—Rash—Temozolomide—malignant glioma	0.00347	0.00395	CcSEcCtD
Glimepiride—Dermatitis—Temozolomide—malignant glioma	0.00346	0.00394	CcSEcCtD
Glimepiride—Headache—Temozolomide—malignant glioma	0.00344	0.00392	CcSEcCtD
Glimepiride—Nausea—Carmustine—malignant glioma	0.00338	0.00385	CcSEcCtD
Glimepiride—ABCC8—central nervous system—malignant glioma	0.00335	0.0506	CbGeAlD
Glimepiride—ABCC8—cerebellum—malignant glioma	0.00328	0.0495	CbGeAlD
Glimepiride—Nausea—Temozolomide—malignant glioma	0.00327	0.00372	CcSEcCtD
Glimepiride—KCNJ11—brain—malignant glioma	0.00289	0.0436	CbGeAlD
Glimepiride—ABCC8—brain—malignant glioma	0.00266	0.0402	CbGeAlD
